Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

32.78
+1.073.37%
Post-market: 33.110.3300+1.01%19:14 EDT
Volume:1.89M
Turnover:62.06M
Market Cap:5.22B
PE:-10.94
High:33.20
Open:32.25
Low:32.01
Close:31.71
Loading ...

Exploring Analyst Estimates for Ionis Pharmaceuticals (IONS) Q4 Earnings, Beyond Revenue and EPS

Zacks
·
17 Feb

Ionis Pharmaceuticals (IONS) Expected to Beat Earnings Estimates: Should You Buy?

Zacks
·
12 Feb

Why Insiders Are Selling Ionis Pharmaceuticals, Inc. (IONS) Recently

Insider Monkey
·
12 Feb

Ionis Pharmaceuticals Says Data Readout From Pelacarsen Study Is Delayed

MT Newswires Live
·
01 Feb

Novartis Edges Higher On Sales Beat As Competition Looms For Its Biggest Moneymaker

Blockhead
·
31 Jan

Ionis ‘remains confident in pelacarsen’ after Novartis update on Phase 3 timing

TIPRANKS
·
31 Jan

FDA & EMA Accept Biogen's Filings for Higher Dose SMA Drug

Zacks
·
24 Jan

Biogen Gets U.S., European Reviews of Higher-Dose Spinraza

Dow Jones
·
23 Jan

Biogen Gets FDA, EMA Approval to Study Higher Dose Regimen of Spinal Muscular Atrophy Treatment

MT Newswires Live
·
23 Jan

FDA and Ema Accept Applications for Higher Dose Regimen of Nusinersen in Sma

THOMSON REUTERS
·
23 Jan

Ionis Pharmaceuticals Insiders Sold US$3.2m Of Shares Suggesting Hesitancy

Simply Wall St.
·
23 Jan

S&P 500 Futures Climb In Premarket Trading; Tempus AI, IDACORP Lead

Dow Jones
·
21 Jan

Intellia Loses 21.6% in a Week: How Should You Play the Stock?

Zacks
·
18 Jan

Why Ionis Pharmaceuticals (IONS) Is the Biotech Stock with Biggest Upside Potential

Insider Monkey
·
18 Jan

Ionis Pharmaceuticals: Strong Pipeline and Market Potential Drive ‘Buy’ Rating

TIPRANKS
·
17 Jan

Ionis Pharmaceuticals (IONS) Gets a Hold from Bernstein

TIPRANKS
·
16 Jan

Ionis Pharmaceuticals Price Target Maintained With a $70.00/Share by RBC Capital

Dow Jones
·
15 Jan

Ionis Pharmaceuticals: Strategic Path to Cash Flow Positivity and Strong Pipeline Drive Buy Rating

TIPRANKS
·
14 Jan

Ionis Pharmaceuticals: Hold Rating Amid Uncertainty in Future Financial Performance

TIPRANKS
·
14 Jan

Ionis unveils pipeline plan for 2025, expects 4 independent product launches

TIPRANKS
·
14 Jan